DOI: https://doi.org/10.14710/jekk.v6i1.9235

Diabetic Status of People Affected by Leprosy in Donorojo Leprosy Recovered Village: A Cross Sectional Study

*Nadhila Beladina  -  Universitas Indonesia, Indonesia
Asri Adisasmita  -  Universitas Indonesia, Indonesia
Received: 21 Oct 2020; Published: 28 Feb 2021.

Citation Format:
Abstract

Background: Just like diabetes, leprosy also cause painless neuropathic ulcers which process is mediated by Schwann-cell. Biochemical changes on leprosy patients presumed to have role on pathogenesis of diabetes mellitus.  

Methods: This study is cross-sectional study aimed to know further about diabetic status on population of people affected by leprosy, as the preliminary study to prove the association between diabetes mellitus and leprosy.  Data, such as diabetic status, type of leprosy, grade of disability, and other variables are collected from 127 people affected by leprosy in Donorojo leprosy recovered village.

Result: Result showed that 19.7% are having diabetes mellitus, and other 23.6% are in pre-diabetic condition. This number is higher than prevalence of diabetes mellitus in Central Java (2.09%) and Indonesia (2%).

Conclusion : Further research is needed to prove the association between leprosy and diabetic status.  All leprosy patients should be recommended to be routinely screened for diabetes mellitus.

Fulltext View|Download
Keywords: Leprosy; diabetes; impaired glucose tolerance; people affected by leprosy
Funding: -

Article Metrics:

Article Info
Section: Articles
Language : EN
Recent articles
Gambaran Activity Daily Living (ADL) Pasien Penyakit Ginjal Kronis yang Menjalani Hemodialisis di RS Setia Mitra Jakarta Correlation Between Total Cholesterol Level with Blood Pressure of Hypertensive Patients in Kalidoni, Palembang Hubungan Pengetahuan Dan Kepatuhan Ibu Hamil Konsumsi Tablet Tambah Darah Dengan Kejadian Anemia Di Kecamatan Leitimur Selatan Dan Teluk Ambon More recent articles
  1. Kassa M, Grace J. 2019. The Global Burden and Perspectives on Non-communicable Diseases (NCDs) and the Prevention, Data Availability and Systems Approach of NCDs in Low-resource Countries. In: Non-communicable Diseases and Urbanization - A Global Perspective [Working Title] [Internet]. IntechOpen; p. 13. Available from: https://www.intechopen.com/books/advanced-biometric-technologies/liveness-detection-in-biometrics
  2. WHO. 2018. Noncommunicable Diseases. 1st ed. Geneva: WHO
  3. Kementerian Kesehatan Republik Indonesia. 2019. Infodatin Hari Diabetes Sedunia Tahun 2018. 1st ed. Pusat Data dan Informasi Kementrian Kesehatan RI. Jakarta: Kementerian Kesehatan Republik Indonesia; 1–8 p
  5. IDF. 2019. IDF Diabetes Atlas 2015 [Internet]. 9th ed. International Diabetes Federation. Brussels: International Diabetes Federation. 39 Available from: http://www.idf.org/about-diabetes/facts-figures
  6. Boulton AJM. 2012. Diabetic foot - what can we learn from leprosy? Legacy of Dr Paul W. Brand. Diabetes Metab Res Rev. 28 (1): 3–7
  7. Kumar D, Banerjee D. 2019. Diabetes and Leprosy: Are they Related?. acta scientific o. 3 (2): 112
  8. Saraya MA, Al-Fadhli MA, Qasem JA. 2012. Diabetic status of patients with leprosy in Kuwait. J Infect Public Health. 5 (5): 360–5
  9. Nigam P, Dayal SG, Srivastava P, Joshi LD, Goyal BM, Dutt B, et al. 1979. Diabetic status in leprosy. Hansenol Int. 4 (1):7–14
  10. Butlin CR, Hossain D, Singh S, Warrender T. 2017. Diabetes amongst Leprosy-Disabled People in Bangladesh: A Cross-sectional Survey. BIRDEM Med J. 6 (2): 100–6
  12. World Health Organization. Global leprosy update, 2018: moving towards a leprosy free world. Wkly Epidemiol Rec [Internet]. 2019;35/36(94):389–412. Available from: https://apps.who.int/iris/bitstream/handle/10665/326775/WER9435-36-en-fr.pdf
  13. World Health Organization. 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia.
  14. Perkumpulan, Endokrinologi, Indonesia, (PERKENI). 2007. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia
  15. Sugumaran DST. 1998 Leprosy Reactions and Complications of Steroid Therapy. Int J Lepr. 66 (I): 10–5
  16. Singh RK, Kumar S, Singh LB. 2013. Diabetic Status Among Leprosy Patients in Referral Centres of Bihar and JharKhand in India.International leprosy congress. (September. 2013)
  17. Kemenkes RI. Profil Kesehatan Indonesia 2018, Kementerian Kesehatan RI, Jakarta [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2019. 207 p. Available from: https://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2018.pdf
  18. Kementrian Kesehatan Republik Indonesia. 2018. Laporan Nasional Riskesdas 2018
  19. http://www.depkes.go.id
  21. Suastika K, Dwipayana P, Siswadi M, Tuty RA. 2012. Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases. In: Glucose Tolerance . InTech
  22. Beisel WR, Sawyer WD, Ryll ED, Crozier D. 1967. Metabolic Effects on Intracellular Infections in Man. Ann Intern Med. 67 (4): 744–79
  23. Garg, R; Agrawal, JK; Bajpai, HS; Singh, G; Srivastava P. 1990. Glucose Tolerance Test in Leprosy. Indian J opf Lepr. 62 (50): 4
  24. Papang R, John AS, Abraham S, Rao P. 2009. A study of steroid-induced diabetes mellitus in leprosy. Indian J opf Lepr. 81 (5): 125–9
  25. Ghosh A. 2019. A Central India Perspective on Leprosy and Its Association with Diabetes Mellitus. J Soc Heal Diabetes. 07 (01): 037–8

Last update:

No citation recorded.

Last update:

No citation recorded.